Partner Headlines - NLNK

  1. Viral Investing: Ebola Drug Makers' Varied Strategies

    IBD
  2. Are There Any Winners Left In The Biotech Space?

    Benzinga
  3. NewLink Genetics Surges 3% Following Ebola Contract News

    Benzinga
  4. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga
  5. NewLink Genetics Sinks On Temporary Halt Of Ebola Trial

    Benzinga
  6. Benzinga's Top #PreMarket Losers

    Benzinga
  7. UPDATE: Stifel Reiterates On NewLink Genetics On Good Risk/Reward

    Benzinga
  8. Mid-Morning Market Update: Markets Edge Lower; DirecTV Profit ...

    Benzinga
  9. Ebola Vaccine Contenders

    Benzinga
  10. Making Money With Charles Payne: 10/24/14

    FoxBusiness
  11. Doctor Who Treated Ebola Patients in West Africa, Tests Positive ...

    Benzinga
  12. The Strongest Biotech Stock In The Market

    Benzinga
  13. CNBC's Stock Pops & Drops From October 20: Pandora, Hertz, CSX ...

    Benzinga
  14. Midday Gainers From October 20: SinoCoking Coal Up 70%, ITT And ...

    Benzinga
  15. Stocks Open Quietly Mixed; Hasbro, NewLink, Akorn Rising

    IBD
  16. Benzinga's Volume Movers

    Benzinga
  17. Morning Market Movers

    Benzinga
  18. Benzinga's Top #PreMarket Gainers

    Benzinga
  19. NewLink Genetics Announces Exclusive Worldwide Licensing Agreement ...

    Benzinga
  20. Stomach-Churning Ride for Ebola Stocks

    FoxBusiness
  21. Making Money With Charles Payne: 10/16/14

    FoxBusiness
  22. Benzinga's Volume Movers

    Benzinga
  23. Markets Rise; Citigroup Profit Beats Street View

    Benzinga
  24. Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear

    IBD
  25. Making Money With Charles Payne: 10/08/14

    FoxBusiness
  26. Ebola Patient Eric Duncan Dies; Related Stocks Fall On News

    Benzinga
  27. Making Money With Charles Payne: 10/07/14

    FoxBusiness
  28. Making Money With Charles Payne: 10/0614

    FoxBusiness
  29. Ebola Sector Shake Out Leaves Chimerix Inc On Top

    Benzinga
  30. Markets Mixed; Constellation Brands Posts Downbeat Profit

    Benzinga
  31. Morning Market Losers

    Benzinga
  32. Benzinga's Top #PreMarket Losers

    Benzinga
  33. Making Money With Charles Payne: 10/01/14

    FoxBusiness
  34. Ebola-Related Pharma Stocks Soar On First U.S. Case

    IBD
  35. Dow Falls More Than 1%; Westport Innovations Shares Dip On Weak ...

    Benzinga
  36. Markets Tumble; Ford September Sales Down 3%

    Benzinga
  37. Benzinga's Volume Movers

    Benzinga
  38. Morning Market Movers

    Benzinga
  39. Making Money With Charles Payne: 09/30/14

    FoxBusiness
  40. Momentum Stocks Showing Weakness

    Benzinga
  41. UPDATE: Mizuho Securities USA Initiates Coverage On NewLink Genetics ...

    Benzinga
  42. Markets Gather Some Momentum As Volume Remains Light, Geopolitical ...

    Benzinga
  43. Markets Open Higher; Wal-Mart Lowers Earnings Forecast

    Benzinga
  44. Mid-Morning Market Update: Markets Drop; Family Dollar Plans ...

    Benzinga
  45. Mid-Day Losers Mar. 7, 2014: PXLW, ALOG, ALSK, NMRX, NLNK, EMAN

    Benzinga
  46. Morning Movers for Mar. 7, 2014: SKUL, DLIA, BIG, GTAT, CCRN, ...

    Benzinga
  47. Benzinga's Top #PreMarket Losers

    Benzinga
  48. Market Wrap For March 3: Markets Lower On Ukraine Tension

    Benzinga
  49. Which Sector Produced 8 Of The 10 Top Percentage Gainers In 2 ...

    Benzinga
  50. NewLink Genetics Corporation Offers a Risky Way to Generate Income

    GuruFocus
  51. NewLink Genetics Corporation Announces Proposed Public Offering ...

    Benzinga
  52. NewLink Genetics Corp (NLNK) Chairman of the Board and CEO Charles ...

    GuruFocus
  53. NewLink Genetics Receives European Orphan Designation for Pancreatic ...

    Benzinga
  54. NewLink Genetics Announces Phase 3 Clinical Trial of algenpantucel-L ...

    Benzinga
  55. These Are Four of the Hottest Biotechs in the Market Right Now

    Benzinga
  56. Weekly CEO Sells Highlight: Universal Insurance Holdings Inc, ...

    GuruFocus
  57. UPDATE: Cantor Fitzgerald Reiterates Buy Rating, Raises PT for ...

    Benzinga
  58. Data From an Investigator-Initiated Phase 2 Study of NewLink ...

    Benzinga
  59. UPDATE: Stifel Nicolaus Initiates Buy, $16 PT on NewLink Genetics

    Benzinga
  60. Canaccord Initiates NewLink Genetics at Buy

    Benzinga
  61. Stifel Nicolaus Initiates Coverage on NDRO, LRE, NLNK

    Benzinga
  62. Cantor Fitzgerald Initiates NewLink Genetics at New Buy

    Benzinga
Trading Center